Quantitative Assessment of AKAP12 Promoter Methylation in Human Prostate Cancer Using Methylation-sensitive High-resolution Melting: Correlation With Gleason Score
Authors:
- Jian GongJGJian Gong
- Jinghui HuJHJinghui Hu
- Tingting HuTHTingting Hu
- Yaofei SunYSYaofei Sun
- Junhua DuJDJunhua Du
- Chuanyu SunCSChuanyu Sun
- Ming GuanMGMing Guan
- Haowen JiangHJHaowen Jiang
- Yuan LuYLYuan Lu
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Age-specific PSA reference ranges in Chinese men without prostate cancerAsian Journal of Andrology, 2008
- Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapyAsian Journal of Andrology, 2008
- Promoter Methylation of Genes in and around the Candidate Lung Cancer Susceptibility Locus6q23-25Cancer Research, 2008
- Hypermethylation of theAKAP12Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic ProgressionCancer Epidemiology, Biomarkers & Prevention, 2008
- Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma CellsCancer Research, 2008
- AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignanciesBritish Journal of Haematology, 2007
- AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activityOncogene, 2004
- High-Resolution Genotyping by Amplicon Melting Analysis Using LCGreenClinical Chemistry, 2003
- Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold proteinCurrent Biology, 1997
- Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.Journal of Clinical Investigation, 1992